A detailed history of Verition Fund Management LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 40,860 shares of AXGN stock, worth $556,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,860
Previous 28,986 40.96%
Holding current value
$556,104
Previous $209,000 173.68%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $14.69 $89,292 - $174,429
11,874 Added 40.96%
40,860 $572,000
Q2 2024

Aug 14, 2024

BUY
$5.67 - $8.06 $164,350 - $233,627
28,986 New
28,986 $209,000
Q1 2023

May 15, 2023

BUY
$7.53 - $10.95 $120,623 - $175,408
16,019 New
16,019 $151,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $575M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.